{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:53:30Z","timestamp":1791269610368,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Serous cystadenocarcinoma (SCAc) of the pancreas is an exceptionally rare malignant pancreatic neoplasm, and its clinical characteristics, treatment patterns, and prognosis remain poorly defined. The aim of this population-based study was to characterize the demographic and clinical features, treatment patterns, and survival of patients with pancreatic SCAc.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with microscopically confirmed SCAc were identified from the Surveillance, Epidemiology, and End Results (SEER) registry. Demographic, tumor-related, treatment, and survival data were analyzed using descriptive statistics and Kaplan-Meier survival analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-one patients with SCAc were identified. Median age at diagnosis was 69 years, and 13 patients (62%) were female. Tumors most frequently involved the pancreatic body or tail. Disease was localized in 4 patients (19%), regional in 6 (29%), distant in 9 (43%), and unstaged in 2 (10%). Surgical resection was performed in 12 patients (57%), and 6 (29%) received chemotherapy. Estimated 5-year overall survival (OS) was 60.5% for the overall cohort. Five-year OS was 73.3% among patients who underwent resection and 44.4% among those who did not.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Pancreatic SCAc is a rare malignancy with frequent involvement of the pancreatic body or tail. Surgical resection was the most common treatment, whereas chemotherapy was used in a minority of patients. Population-based data suggest relatively favorable long-term survival.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12957-026-04604-z","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T05:34:19Z","timestamp":1790573659000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serous cystadenocarcinoma of the pancreas: a population-based study"],"prefix":"10.1186","volume":"24","author":[{"given":"Theodore","family":"Dotevall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emelie","family":"Kolmodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebba","family":"Thylefors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4357-822X","authenticated-orcid":false,"given":"Daniel","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"4604_CR1","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1136\/gutjnl-2015-309638","volume":"65","author":"B Jais","year":"2016","unstructured":"Jais B, Rebours V, Malleo G, Salvia R, Fontana M, Maggino L, Bassi C, Manfredi R, Moran R, Lennon AM, et al. Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas). Gut. 2016;65:305\u201312.","journal-title":"Gut"},{"key":"4604_CR2","unstructured":"Singhi AD, Adsay NV, Hiraoka N, Terris B. Serous neoplasms of the pancreas. In: WHO Classification of Tumours Editorial Board. WHO Classification of Tumours: Digestive System Tumours. 5th ed. Lyon: International Agency for Research on Cancer; 2019:303\u20136."},{"key":"4604_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/00000478-198901000-00009","volume":"13","author":"DH George","year":"1989","unstructured":"George DH, Murphy F, Michalski R, Ulmer BG. Serous cystadenocarcinoma of the pancreas: a new entity? Am J Surg Pathol. 1989;13:61\u20136.","journal-title":"Am J Surg Pathol"},{"key":"4604_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12876-016-0518-0","volume":"16","author":"J Huh","year":"2016","unstructured":"Huh J, Byun JH, Hong SM, Kim KW, Kim JH, Lee SS, Kim HJ, Lee MG. Malignant pancreatic serous cystic neoplasms: systematic review with a new case. BMC Gastroenterol. 2016;16:97.","journal-title":"BMC Gastroenterol"},{"key":"4604_CR5","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1097\/PAS.0000000000000559","volume":"39","author":"MD Reid","year":"2015","unstructured":"Reid MD, Choi HJ, Memis B, Krasinskas AM, Jang KT, Akkas G, Maithel SK, Sarmiento JM, Kooby DA, Basturk O, Adsay V. Serous Neoplasms of the Pancreas: A Clinicopathologic Analysis of 193 Cases and Literature Review With New Insights on Macrocystic and Solid Variants and Critical Reappraisal of So-called Serous Cystadenocarcinoma. Am J Surg Pathol. 2015;39:1597\u2013610.","journal-title":"Am J Surg Pathol"},{"key":"4604_CR6","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1136\/jcp-2025-210480","volume":"79","author":"C Tan","year":"2026","unstructured":"Tan C, Chen X, Ni SJ, Zhang M, Cai X, Jiang W, Sheng W, Huang D. Risk stratification in locally invasive pancreatic serous cystic neoplasms: systematic review and two cases. J Clin Pathol. 2026;79:541\u20137.","journal-title":"J Clin Pathol"},{"key":"4604_CR7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s12328-021-01570-9","volume":"15","author":"Y Takagi","year":"2022","unstructured":"Takagi Y, Hatori T, Itano O, Shinoda M, Kato A, Nitori N, Kato F, Kato A, Nakao A, Tamura T, et al. Pancreatic serous cystadenocarcinoma diagnosed with liver metastasis at 7 years after the resection of the primary serous neoplastic lesion. Clin J Gastroenterol. 2022;15:505\u201312.","journal-title":"Clin J Gastroenterol"},{"key":"4604_CR8","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1177\/00031348261419750","volume":"92","author":"S Wilhelm","year":"2026","unstructured":"Wilhelm S, Davis RT, Tolkacz M, Studzinski D, Callahan R, DeMare AM. Serous Cystadenocarcinoma of the Pancreas: A Systematic Review of Presentation, Management, and Outcomes. Am Surg. 2026;92:1773\u20139.","journal-title":"Am Surg"},{"key":"4604_CR9","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER Research Limited-Field Data, 21 Registries (excl IL), Nov 2025 Sub (2000-2023), National Cancer Institute, DCCPS, Surveillance Research Program, released April 2026, based on the November 2025 submission."},{"key":"4604_CR10","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1007\/s11605-009-0926-3","volume":"13","author":"JC King","year":"2009","unstructured":"King JC, Ng TT, White SC, Cortina G, Reber HA, Hines OJ. Pancreatic serous cystadenocarcinoma: a case report and review of the literature. J Gastrointest Surg. 2009;13:1864\u20138.","journal-title":"J Gastrointest Surg"},{"key":"4604_CR11","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/01.sla.0000179651.21193.2c","volume":"242","author":"JF Tseng","year":"2005","unstructured":"Tseng JF, Warshaw AL, Sahani DV, Lauwers GY, Rattner DW, Fernandez-del Castillo C. Serous cystadenoma of the pancreas: tumor growth rates and recommendations for treatment. Ann Surg. 2005;242:413\u20139. discussion 419\u2013421.","journal-title":"Ann Surg"},{"key":"4604_CR12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s005340050075","volume":"5","author":"N Eriguchi","year":"1998","unstructured":"Eriguchi N, Aoyagi S, Nakayama T, Hara M, Miyazaki T, Kutami R, Jimi A. Serous cystadenocarcinoma of the pancreas with liver metastases. J Hepatobiliary Pancreat Surg. 1998;5:467\u201370.","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"4604_CR13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/jgh.13036","volume":"31","author":"H Sasaki","year":"2016","unstructured":"Sasaki H, Murakami Y, Uemura K, Hashimoto Y, Kondo N, Nakagawa N, Sueda T. Education and imaging. Hepatobiliary and Pancreatic: Long-term survival of serous cystadenocarcinoma of the pancreas with synchronous liver metastases after aggressive surgical resection. J Gastroenterol Hepatol. 2016;31:287.","journal-title":"J Gastroenterol Hepatol"},{"key":"4604_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s40792-021-01239-y","volume":"7","author":"T Kokumai","year":"2021","unstructured":"Kokumai T, Mizuma M, Hirose K, Karasawa H, Ishida M, Ohtsuka H, Nakagawa K, Morikawa T, Kamei T, Masamune A, et al. A long-term survivor of metachronous liver metastases of pancreatic serous cystic neoplasm associated with von Hippel-Lindau disease. Surg Case Rep. 2021;7:155.","journal-title":"Surg Case Rep"},{"key":"4604_CR15","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.pan.2015.09.009","volume":"15","author":"MC Machado","year":"2015","unstructured":"Machado MC, Fonseca GM, de Meirelles LR, Siqueira LT, Katz B, Jukemura J. Synchronous resection of pancreatic serous cystadenocarcinoma and liver metastasis: First reported case and review of literature. Pancreatology. 2015;15:708\u201312.","journal-title":"Pancreatology"},{"key":"4604_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1477-7819-10-51","volume":"10","author":"K Bramis","year":"2012","unstructured":"Bramis K, Petrou A, Papalambros A, Manzelli A, Mantonakis E, Brennan N, Felekouras E. Serous cystadenocarcinoma of the pancreas: report of a case and management reflections. World J Surg Oncol. 2012;10:51.","journal-title":"World J Surg Oncol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04604-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04604-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04604-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:37:27Z","timestamp":1791268647000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04604-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4604"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04604-z","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"13 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The SEER registry provides fully de-identified, patient-level data. The study protocol was approved by the Swedish Ethical Review Authority (approval no. 2024-02360-01), which waived the requirement for informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"389"}}